News
Officials at Lonza say they will invest in additional bioconjugation capabilities in Visp, Switzerland. The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing ...
Ten23 health, a CDMO that launched just six months ago, continues to expand (PDF) its manufacturing facility in Visp, Switzerland. The contract drug manufacturer will add an additional 1,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback